Stefanie Flohr, Novartis Institutes for Biomedical Research (NIBR); Anna Schubart, Novartis Institutes for Biomedical Research (NIBR)

Discovery of highly potent, selective and orally bioavailable complement alternative pathway inhibitors

Start Date	20.09.2017 - 17:00
Event End	20.09.2017 - 18:00
Location	Universität Basel, Pharmazentrum

Discovery of highly potent, selective and orally bioavailable complement alternative pathway inhibitors